MedTrace Logo

Study of IFN-K in Dermatomyositis

NCT02980198 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2020-01-03

No results posted yet for this study

Summary

This study is a Proof of Concept study aiming to evaluate the production of anti-IFNα antibodies (immune response) in adult subjects with dermatomyositis

Conditions

  • Dermatomyositis

Interventions

BIOLOGICAL

IFN-Kinoid

IM administration

OTHER

Placebo

IM administration

OTHER

ISA 51

adjuvant

Sponsors & Collaborators

  • Neovacs

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-03
Primary Completion
2019-12-11
Completion
2019-12-11

Countries

  • France
  • Germany
  • Italy
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02980198 on ClinicalTrials.gov